AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
SURFACTANT THERAPY RESTORES GAS-EXCHANGE IN LUNG INJURY DUE TO PARAQUAT INTOXICATION IN RATS
Authors: SO KL DEBUIJZER E GOMMERS D KAISERS U VANGENDEREN PJJ LACHMANN B
Citation: Kl. So et al., SURFACTANT THERAPY RESTORES GAS-EXCHANGE IN LUNG INJURY DUE TO PARAQUAT INTOXICATION IN RATS, The European respiratory journal, 12(2), 1998, pp. 284-287
QUANTITATIVE-ANALYSIS OF VON-WILLEBRAND-FACTOR AND ITS PROPEPTIDE IN PLASMA IN ACQUIRED VON-WILLEBRAND SYNDROME
Authors: VANGENDEREN PJJ BOERTJES RC VANMOURIK JA
Citation: Pjj. Vangenderen et al., QUANTITATIVE-ANALYSIS OF VON-WILLEBRAND-FACTOR AND ITS PROPEPTIDE IN PLASMA IN ACQUIRED VON-WILLEBRAND SYNDROME, Thrombosis and haemostasis, 80(3), 1998, pp. 495-498
COAGULATION DISORDERS IN YOUNG-ADULTS WITH ACUTE CEREBRAL-ISCHEMIA
Authors: MUNTS AG VANGENDEREN PJJ DIPPEL DWJ VANKOOTEN F KOUDSTAAL PJ
Citation: Ag. Munts et al., COAGULATION DISORDERS IN YOUNG-ADULTS WITH ACUTE CEREBRAL-ISCHEMIA, Journal of neurology, 245(1), 1998, pp. 21-25
SPONTANEOUS PLATELET ACTIVATION IN-VIVO AS A CAUSE OF PLATELET-MEDIATED THROMBOSIS IN THROMBOCYTHEMIA - RATIONALE FOR USING LOW-DOSE ASPIRIN AS A SAFE AND EFFECTIVE ANTITHROMBOTIC AGENT
Authors: MICHIELS JJ VANGENDEREN PJJ SCHROR K
Citation: Jj. Michiels et al., SPONTANEOUS PLATELET ACTIVATION IN-VIVO AS A CAUSE OF PLATELET-MEDIATED THROMBOSIS IN THROMBOCYTHEMIA - RATIONALE FOR USING LOW-DOSE ASPIRIN AS A SAFE AND EFFECTIVE ANTITHROMBOTIC AGENT, British Journal of Haematology, 102(1), 1998, pp. 359-359
EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTORMULTIMERS IN PLASMA
Authors: VANGENDEREN PJJ VANVLIET HHDM PRINS FJ VANDEMOESDIJK D VANSTRIK R ZIJLSTRA FJ BUDDE U MICHIELS JJ
Citation: Pjj. Vangenderen et al., EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTORMULTIMERS IN PLASMA, Annals of hematology, 75(5-6), 1997, pp. 215-220
INCREASED TURNOVER OF COLLAGEN-BINDING ACTIVITY OF VON-WILLEBRAND-FACTOR IN PLASMA IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA - REVERSAL AFTER NORMALIZATION OF THE INCREASED PLATELET COUNT
Authors: VANGENDEREN PJJ PRINS FJ LUCAS IS VANDEMOESDIJK D VANVLIET HHDM MICHIELS JJ
Citation: Pjj. Vangenderen et al., INCREASED TURNOVER OF COLLAGEN-BINDING ACTIVITY OF VON-WILLEBRAND-FACTOR IN PLASMA IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA - REVERSAL AFTER NORMALIZATION OF THE INCREASED PLATELET COUNT, Thrombosis and haemostasis, 1997, pp. 187-187
THE EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA
Authors: VANGENDEREN PJJ VANVLIET HHDM PRINS FJ VANDEMOESDIJK D VANSTRIK R ZIJLSTRA FJ BUDDE U MICHIELS JJ
Citation: Pjj. Vangenderen et al., THE EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA, Thrombosis and haemostasis, 1997, pp. 2358-2358
DECREASED HALF-LIFE TIME OF PLASMA VON-WILLEBRAND-FACTOR COLLAGEN-BINDING ACTIVITY IN ESSENTIAL THROMBOCYTHEMIA - NORMALIZATION AFTER CYTOREDUCTION OF THE INCREASED PLATELET COUNT
Authors: VANGENDEREN PJJ PRINS FJ LUCAS IS VANDEMOESDIJK D VANVLIET HHDM VANSTRIK R MICHIELS JJ
Citation: Pjj. Vangenderen et al., DECREASED HALF-LIFE TIME OF PLASMA VON-WILLEBRAND-FACTOR COLLAGEN-BINDING ACTIVITY IN ESSENTIAL THROMBOCYTHEMIA - NORMALIZATION AFTER CYTOREDUCTION OF THE INCREASED PLATELET COUNT, British Journal of Haematology, 99(4), 1997, pp. 832-836
PREVENTION AND TREATMENT OF THROMBOTIC COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA - EFFICACY AND SAFETY OF ASPIRIN
Authors: VANGENDEREN PJJ MULDER PGH WALEBOER M VANDEMOESDIJK D MICHIELS JJ
Citation: Pjj. Vangenderen et al., PREVENTION AND TREATMENT OF THROMBOTIC COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA - EFFICACY AND SAFETY OF ASPIRIN, British Journal of Haematology, 97(1), 1997, pp. 179-184
ERYTHROMELALGIC, THROMBOTIC AND HEMORRHAGIC MANIFESTATIONS IN 50 CASES OF THROMBOCYTHEMIA
Authors: MICHIELS JJ VANGENDEREN PJJ LINDEMANS J VANVLIET HHDM
Citation: Jj. Michiels et al., ERYTHROMELALGIC, THROMBOTIC AND HEMORRHAGIC MANIFESTATIONS IN 50 CASES OF THROMBOCYTHEMIA, Leukemia & lymphoma, 22, 1996, pp. 47-56
ATYPICAL TRANSIENT ISCHEMIC ATTACKS IN THROMBOCYTHEMIA OF VARIOUS MYELOPROLIFERATIVE DISORDERS
Authors: MICHIELS JJ VANGENDEREN PJJ JANSEN PHP KOUDSTAAL PJ
Citation: Jj. Michiels et al., ATYPICAL TRANSIENT ISCHEMIC ATTACKS IN THROMBOCYTHEMIA OF VARIOUS MYELOPROLIFERATIVE DISORDERS, Leukemia & lymphoma, 22, 1996, pp. 65-70
ACQUIRED VON-WILLEBRAND DISEASE IN MYELOPROLIFERATIVE DISORDERS
Authors: VANGENDEREN PJJ LEENKNEGT H MICHIELS JJ BUDDE U
Citation: Pjj. Vangenderen et al., ACQUIRED VON-WILLEBRAND DISEASE IN MYELOPROLIFERATIVE DISORDERS, Leukemia & lymphoma, 22, 1996, pp. 79-82
ERYTHROMELALGIA IN ESSENTIAL THROMBOCYTHEMIA IS CHARACTERIZED BY PLATELET ACTIVATION AND ENDOTHELIAL-CELL DAMAGE BUT NOT BY THROMBIN GENERATION
Authors: VANGENDEREN PJJ LUCAS IS VANSTRIK R VUZEVSKI VD PRINS FJ VANVLIET HHDM MICHIELS JJ
Citation: Pjj. Vangenderen et al., ERYTHROMELALGIA IN ESSENTIAL THROMBOCYTHEMIA IS CHARACTERIZED BY PLATELET ACTIVATION AND ENDOTHELIAL-CELL DAMAGE BUT NOT BY THROMBIN GENERATION, Thrombosis and haemostasis, 76(3), 1996, pp. 333-338
THE REDUCTION OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO THE PLATELET COUNT
Authors: VANGENDEREN PJJ BUDDE U MICHIELS JJ VANSTRIK R VANVLIET HHDM
Citation: Pjj. Vangenderen et al., THE REDUCTION OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO THE PLATELET COUNT, British Journal of Haematology, 93(4), 1996, pp. 962-965
BASIC CONCEPT OF SPECIFIC VASCULAR MANIFESTATIONS IN ESSENTIAL THROMBOCYTHEMIA CAUSED BY PLATELET DEPENDENT ISCHEMIC, THROMBOTIC AND INFLAMMATORY PROCESSES
Authors: MICHIELS JJ VANGENDEREN PJJ VANVLLET HDM
Citation: Jj. Michiels et al., BASIC CONCEPT OF SPECIFIC VASCULAR MANIFESTATIONS IN ESSENTIAL THROMBOCYTHEMIA CAUSED BY PLATELET DEPENDENT ISCHEMIC, THROMBOTIC AND INFLAMMATORY PROCESSES, Thrombosis and haemostasis, 73(6), 1995, pp. 955-955
DECREASE OF PLASMA VON-WILLEBRAND-FACTOR IN HIGH PLATELET COUNT STATES IS RELATED TO THE NUMBER OF PLATELETS CIRCULATING IN BLOOD
Authors: VANGENDEREN PJJ BUDDE U MICHIELS JJ VANVLIET HHDM
Citation: Pjj. Vangenderen et al., DECREASE OF PLASMA VON-WILLEBRAND-FACTOR IN HIGH PLATELET COUNT STATES IS RELATED TO THE NUMBER OF PLATELETS CIRCULATING IN BLOOD, Thrombosis and haemostasis, 73(6), 1995, pp. 1162-1162
HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN DELAYS CLEARANCE OF VON-WILLEBRAND-FACTOR IN ACQUIRED VON-WILLEBRAND DISEASE
Authors: VANGENDEREN PJJ TERPSTRA W MICHIELS JJ KAPTEIJN L VANVLIET HHDM
Citation: Pjj. Vangenderen et al., HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN DELAYS CLEARANCE OF VON-WILLEBRAND-FACTOR IN ACQUIRED VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 73(5), 1995, pp. 891-892
PLATELET CONSUMPTION IN THROMBOCYTHEMIA COMPLICATED BY ERYTHROMELALGIA - REVERSAL BY ASPIRIN
Authors: VANGENDEREN PJJ MICHIELS JJ VANSTRIK R LINDEMANS J VANVLIET HHDM
Citation: Pjj. Vangenderen et al., PLATELET CONSUMPTION IN THROMBOCYTHEMIA COMPLICATED BY ERYTHROMELALGIA - REVERSAL BY ASPIRIN, Thrombosis and haemostasis, 73(2), 1995, pp. 210-214
HYDROXYUREA IN ESSENTIAL THROMBOCYTOSIS
Authors: VANGENDEREN PJJ MICHIELS JJ
Citation: Pjj. Vangenderen et Jj. Michiels, HYDROXYUREA IN ESSENTIAL THROMBOCYTOSIS, The New England journal of medicine, 333(12), 1995, pp. 802-803
ACQUIRED VON-WILLEBRAND DISEASE AS A CAUSE OF RECURRENT MUCOCUTANEOUSBLEEDING IN PRIMARY THROMBOCYTHEMIA - RELATIONSHIP WITH PLATELET COUNT
Authors: VANGENDEREN PJJ MICHIELS JJ VANDERPOELVANDELUYTGAARDE SCPAM VANVLIET HHDM
Citation: Pjj. Vangenderen et al., ACQUIRED VON-WILLEBRAND DISEASE AS A CAUSE OF RECURRENT MUCOCUTANEOUSBLEEDING IN PRIMARY THROMBOCYTHEMIA - RELATIONSHIP WITH PLATELET COUNT, Annals of hematology, 69(2), 1994, pp. 81-84
ERYTHROMELALGIC, THROMBOTIC AND HEMORRHAGIC MANIFESTATIONS OF THROMBOCYTHEMIA
Authors: VANGENDEREN PJJ MICHIELS JJ
Citation: Pjj. Vangenderen et Jj. Michiels, ERYTHROMELALGIC, THROMBOTIC AND HEMORRHAGIC MANIFESTATIONS OF THROMBOCYTHEMIA, La Presse medicale, 23(2), 1994, pp. 73-77
LIPOXYGENASE DEFICIENCY IN PRIMARY THROMBOCYTHEMIA IS NOT A TRUE DEFICIENCY
Authors: VANGENDEREN PJJ MICHIELS JJ ZIJLSTRA FJ
Citation: Pjj. Vangenderen et al., LIPOXYGENASE DEFICIENCY IN PRIMARY THROMBOCYTHEMIA IS NOT A TRUE DEFICIENCY, Thrombosis and haemostasis, 71(6), 1994, pp. 803-804
THE RELIABILITY OF HICKMAN CATHETER BLOOD FOR THE ASSESSMENT OF ACTIVATION MARKERS OF COAGULATION AND FIBRINOLYSIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: VANGENDEREN PJJ GOMES M STIBBE J
Citation: Pjj. Vangenderen et al., THE RELIABILITY OF HICKMAN CATHETER BLOOD FOR THE ASSESSMENT OF ACTIVATION MARKERS OF COAGULATION AND FIBRINOLYSIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Thrombosis research, 73(3-4), 1994, pp. 247-254
EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN THERAPY IN ACQUIRED VON-WILLEBRANDS-DISEASE (VOL 67, PG 14, 1994)
Authors: VANGENDEREN PJJ
Citation: Pjj. Vangenderen, EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN THERAPY IN ACQUIRED VON-WILLEBRANDS-DISEASE (VOL 67, PG 14, 1994), Vox sanguinis, 67(3), 1994, pp. 322-322
EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN THERAPY IN ACQUIRED VON WILLEBRANDS DISEASE
Authors: VANGENDEREN PJJ MICHIELS JJ BAKKER JJ VANTVEER MB
Citation: Pjj. Vangenderen et al., EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN THERAPY IN ACQUIRED VON WILLEBRANDS DISEASE, Vox sanguinis, 67(1), 1994, pp. 14-17
Risultati: 1-25 | 26-35